肠延缓释放颗粒载荷 登德罗宾 通过调节肠道植物组成,改善小鼠的高脂血症
Shunqiang Song1,2, Liangyu Yang1,2, Tingting Chen1,2
1Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
Pharmaceutics
|November 27, 2024
概括
肠延缓释放登德罗宾 (DNL) 颗粒通过改善小鼠肠道微生物群平衡来有效治疗高脂血症. 这项研究证明了DNL.
科学领域:
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 超脂血症与肠道菌群的失衡有关.
- 开发有针对性的疗法来调节肠道微生物群对于管理高脂血症至关重要.
研究的目的:
- 用于制造装载着丹德罗宾 (DNL) 的肠延缓释放颗粒.
- 研究DNL颗粒对超脂性小鼠肠道菌群的低脂性作用和潜在机制.
主要方法:
- 使用FT-IR,XRD,SEM和DSC进行了DNL的合成和表征.
- 使用高脂肪饮食建立了一个超脂血症小鼠模型.
- 用药学动力学研究和16S rRNA高通量测序来分析肠道微生物群的组成和功能.
主要成果:
- 在超脂症小鼠 (p < 0.05) 中,DNL颗粒显著降低了体重和血脂水平.
- DNL治疗调节了肠道菌群,增加了像Actinobacteria和厚壁细菌这样的有益细菌.
- DNL减少了诸如Desulfovibrio和Mycobacterium anisopliae之类的有害细菌,从而抑制了致病微生物.
结论:
- 肠延缓释放DNL颗粒显示出显著的低脂血效.
- DNL治疗恢复了肠道菌群的平衡,这表明了高脂血症的新疗法.
- 用DNL调节肠道微生物群为管理高脂血症提供了一个有希望的方法.
更多相关视频
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...